Upstream Bio, Inc. Financial Ratios
UPB / Health Care|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 8.68 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
-42.2%
Profit Margin
-5026.0%
Net Income / Revenue
Asset Turnover
0.01
Revenue / Total Assets
Equity Multiplier
1.04
Total Assets / Equity
Composite: -42.2% (reported: -42.2%)
Profitability
Liquidity
Current Ratio
26.15
Quick Ratio
26.15
Solvency
Interest Coverage
-
Efficiency
Asset Turnover
0.01
Inventory Turnover
-
Days Sales Outstanding
85 days
As of FY2025 · SEC 10-K · Updated Jun 30, 2026
Earnings Quality
Accrual Ratio
-2.4%
-6.0pp YoY
Earnings are roughly in line with operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.